Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
NCT00924703
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Phenylketonuria
Interventions
DRUG:
rAvPAL-PEG
Sponsor
BioMarin Pharmaceutical